Boston Scientific Corp (BSX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Boston Scientific Corp (BSX) has a cash flow conversion efficiency ratio of 0.013x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($348.00 Million) by net assets ($26.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BSX equity financing ratio to measure how much of total assets are equity-financed.
Boston Scientific Corp - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Boston Scientific Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BSX cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Boston Scientific Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Boston Scientific Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lumentum Holdings Inc
NASDAQ:LITE
|
0.069x |
|
Warner Bros Discovery Inc
NASDAQ:WBD
|
-0.006x |
|
OVERSEA-CHIN.UNSP.ADR/2
F:OCBB
|
N/A |
|
Nippon Telegraph and Telephone Corporation
F:NLV
|
0.099x |
|
Republic Services Inc
NYSE:RSG
|
0.102x |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
0.034x |
|
Comfort Systems USA Inc
NYSE:FIX
|
0.138x |
|
Atlas Copco A ADR
F:ACO
|
0.044x |
Annual Cash Flow Conversion Efficiency for Boston Scientific Corp (1991–2025)
The table below shows the annual cash flow conversion efficiency of Boston Scientific Corp from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Boston Scientific Corp.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $24.47 Billion | $4.53 Billion | 0.185x | +18.68% |
| 2024-12-31 | $22.00 Billion | $3.44 Billion | 0.156x | +21.81% |
| 2023-12-31 | $19.53 Billion | $2.50 Billion | 0.128x | +47.60% |
| 2022-12-31 | $17.57 Billion | $1.53 Billion | 0.087x | -22.81% |
| 2021-12-31 | $16.62 Billion | $1.87 Billion | 0.112x | +14.34% |
| 2020-12-31 | $15.33 Billion | $1.51 Billion | 0.098x | -25.64% |
| 2019-12-31 | $13.88 Billion | $1.84 Billion | 0.132x | +272.38% |
| 2018-12-31 | $8.72 Billion | $310.00 Million | 0.036x | -82.53% |
| 2017-12-31 | $7.01 Billion | $1.43 Billion | 0.203x | +40.89% |
| 2016-12-31 | $6.73 Billion | $972.00 Million | 0.144x | +52.06% |
| 2015-12-31 | $6.32 Billion | $600.00 Million | 0.095x | -48.81% |
| 2014-12-31 | $6.84 Billion | $1.27 Billion | 0.185x | +12.07% |
| 2013-12-31 | $6.54 Billion | $1.08 Billion | 0.165x | -9.78% |
| 2012-12-31 | $6.87 Billion | $1.26 Billion | 0.183x | +106.57% |
| 2011-12-31 | $11.35 Billion | $1.01 Billion | 0.089x | +208.60% |
| 2010-12-31 | $11.30 Billion | $325.00 Million | 0.029x | -57.61% |
| 2009-12-31 | $12.30 Billion | $835.00 Million | 0.068x | -26.66% |
| 2008-12-31 | $13.14 Billion | $1.22 Billion | 0.093x | +49.61% |
| 2007-12-31 | $15.10 Billion | $934.00 Million | 0.062x | -48.70% |
| 2006-12-31 | $15.30 Billion | $1.84 Billion | 0.121x | -42.81% |
| 2005-12-31 | $4.28 Billion | $903.00 Million | 0.211x | -52.95% |
| 2004-12-31 | $4.03 Billion | $1.80 Billion | 0.448x | +62.99% |
| 2003-12-31 | $2.86 Billion | $787.00 Million | 0.275x | -7.83% |
| 2002-12-31 | $2.47 Billion | $736.00 Million | 0.298x | +22.68% |
| 2001-12-31 | $2.02 Billion | $490.00 Million | 0.243x | -36.33% |
| 2000-12-31 | $1.94 Billion | $739.00 Million | 0.382x | -9.43% |
| 1999-12-31 | $1.72 Billion | $727.00 Million | 0.422x | +33.95% |
| 1998-12-31 | $821.10 Million | $258.50 Million | 0.315x | +285.69% |
| 1997-12-31 | $986.20 Million | $80.50 Million | 0.082x | -44.31% |
| 1996-12-31 | $916.30 Million | $134.30 Million | 0.147x | +341.46% |
| 1995-12-31 | $753.00 Million | $25.00 Million | 0.033x | -83.35% |
| 1994-12-31 | $340.00 Million | $67.80 Million | 0.199x | -25.24% |
| 1993-12-31 | $246.70 Million | $65.80 Million | 0.267x | +56.33% |
| 1992-12-31 | $249.10 Million | $42.50 Million | 0.171x | -47.95% |
| 1991-12-31 | $90.30 Million | $29.60 Million | 0.328x | -- |
About Boston Scientific Corp
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyG… Read more